Literature DB >> 2075784

HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.

A Goday1, E Motaña, G Ercilla, J Fernandez, R Gomis, E Vilardell.   

Abstract

The HLA haplotype and its relationships with clinical, biological and immunological parameters were analyzed in a group of 87 Spanish type 1 diabetic patients at the clinical onset of the disease. The frequency of HLA-B18, DR3 and DR4 antigens was significantly increased whereas DR2, DR5 and DR7 were decreased in comparison with 189 healthy unrelated controls without family history of diabetes. DR3 showed a maximum relative risk for diabetes (5.5) whereas DR4 had a lower one (4.0). HLA-DR4 patients were younger at the time of diagnosis than DR4 negative (16.7 vs 21.4 years). We found no statistically significant relationship between HLA antigens and the other variables studied including the presence of islet cell antibodies, complement fixing islet cell antibodies, insulin autoantibodies, organ-specific antibodies, fasting and maximal glucagon stimulated C-peptide levels, initial glycemia and glycosylated hemoglobin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2075784     DOI: 10.1007/BF02581333

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  26 in total

1.  HLA-D--related (DRw) antigens in juvenile diabetes mellitus.

Authors:  N R Farid; L Sampson; P Noel; J M Barnard; A J Davis; D A Hillman
Journal:  Diabetes       Date:  1979-06       Impact factor: 9.461

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families.

Authors:  L Contu; I Deschamps; H Lestradet; J Hors; M Schmid; M Busson; A Benajam; A Marcelli-Barge; J Dausset
Journal:  Tissue Antigens       Date:  1982-08

4.  Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.

Authors:  H Gleichmann; B Zörcher; B Greulich; F A Gries; H R Henrichs; J Betrams; H Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

5.  Genetic heterogeneity of diabetes and HLA.

Authors:  J Barbosa; F H Bach; S S Rich
Journal:  Clin Genet       Date:  1982-01       Impact factor: 4.438

6.  Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population.

Authors:  G Pagano; P Cavallo-Perin; F Cavalot; A M Dall'Omo; P Masciola; R Suriani; A Amoroso; S E Curtoni; I Borelli; G Lenti
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

7.  The HLA-D associations of type 1 (insulin-dependent) diabetes in Punjabi Asians in the United Kingdom.

Authors:  O Odugbesan; J Fletcher; C Mijovic; E Mackay; A R Bradwell; A H Barnett
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

8.  Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.

Authors:  L Groop; A Miettinen; P H Groop; S Meri; S Koskimies; G F Bottazzo
Journal:  Diabetes       Date:  1988-01       Impact factor: 9.461

9.  Prospective study of predictors of beta-cell survival in type I diabetes.

Authors:  A Schiffrin; S Suissa; P Poussier; R Guttmann; G Weitzner
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.